📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2. (2023)

First Author: Grant MD

Attributed to: Systematic characterisation of the HCMV pathogenicity domain spontaneously lost from commonly used passaged strains funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.170681

PubMed Identifier: 37338994

Publication URI: http://europepmc.org/abstract/MED/37338994

Type: Journal Article/Review

Volume: 8

Parent Publication: JCI insight

Issue: 15

ISSN: 2379-3708